Breast imaging computer-aided detection (CAD) software developer CureMetrix has won a contract with DocPanel to develop breast cancer second-opinion software based on artificial intelligence (AI) for the teleradiology provider's second-opinion program.
In March, the U.S. Food and Drug Administration (FDA) cleared CureMetrix's cmTriage, software that allows for triaging of screening mammography exams, the company said.
